Calidi Biotherapeutics, Inc. (CLDI)

NYSEAMERICAN: CLDI · Real-Time Price · USD

0.2805

-0.0145 (-4.92%)

Jun 20, 2025, 4:00 PM - Market closed

Calidi Biotherapeutics Employees

Calidi Biotherapeutics had 28 employees as of December 31, 2024. The number of employees decreased by 13 or -31.71% compared to the previous year.

Employees

28

Change (1Y)

-13

Growth (1Y)

-31.71%

Revenue / Employee

n/a

Profits / Employee

-$770,536

Market Cap

9.42M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	28	-13	-31.71%
Dec 31, 2023	41	3	7.89%
Dec 31, 2022	38	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

CLDI News

4 weeks ago - Innovation In Indexing: Why Passive ETFs Matter - ETF Trends
2 months ago - Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
2 months ago - Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds - PRNewsWire
2 months ago - Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire
3 months ago - Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire
3 months ago - Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform - GlobeNewsWire
4 months ago - Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
4 months ago - Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital - GlobeNewsWire